The global electroretinogram market was valued at USD 63.75 million in 2025 and is projected to grow from USD 69.06 million in 2026 to USD 130.98 million by 2034, registering a CAGR of 8.33% during 2026–2034. Asia-Pacific dominated the market with a 34.2% share in 2025, while Europe is expected to register the fastest growth. Rising cases of retinal disorders, an aging population, and advancements in ophthalmic diagnostic technologies are supporting market expansion.
Electroretinogram Market Trends
Advancements in Portable Electroretinography Devices
Technological improvements in compact diagnostic equipment are encouraging the adoption of handheld electroretinogram devices. Portable systems allow ophthalmologists to assess retinal function in clinics, community healthcare facilities, and locations with limited diagnostic infrastructure. Devices such as LKC Technologies' RETeval support convenient retinal testing and improve access to electroretinography services.
Integration of Advanced Retinal Diagnostic Technologies
The integration of digital analysis, automated testing, and advanced electrophysiological measurement is improving retinal assessment. Multifocal electroretinography and pattern electroretinography provide detailed information about retinal responses and help clinicians evaluate specific retinal abnormalities. These technologies are supporting more precise diagnostic procedures and expanding the use of ERG systems in specialized eye care.
Electroretinogram Market Growth Drivers
Rising Prevalence of Retinal Disorders and Aging Population
The growing incidence of glaucoma, diabetic retinopathy, inherited retinal diseases, and other vision-related conditions is increasing demand for advanced diagnostic procedures. Older adults face a higher risk of several retinal disorders, creating a larger patient population requiring regular eye examinations. Hospitals and ophthalmology centers are adopting electroretinogram systems to evaluate retinal function and support the diagnosis of vision abnormalities.
Electroretinogram Market Opportunities and Restraints
Expansion of Ophthalmic Diagnostic Infrastructure
Medical device manufacturers, ophthalmology clinics, and healthcare technology providers have opportunities to expand electroretinography services in emerging markets. Investments in eye care infrastructure across India, China, and Southeast Asia can increase demand for portable and cost-effective diagnostic systems. Companies offering user-friendly devices, training, and integrated diagnostic solutions can strengthen their market presence.
High Equipment Costs and Limited Clinical Awareness
Advanced electroretinogram systems require specialized equipment, trained professionals, and appropriate testing facilities. These requirements can increase the cost of adoption for smaller hospitals and eye care centers. Limited awareness of ERG testing among patients and healthcare providers may also restrict its use in regions where access to specialized ophthalmic services remains limited.
Electroretinogram Market Regional Outlook
Asia-Pacific held the largest market share in 2025, accounting for 34.2% of global revenue. A large patient population, rising prevalence of eye disorders, expanding healthcare infrastructure, and growing investments in ophthalmic diagnostics across China, India, and Japan support regional demand.
Europe is expected to register the fastest growth during the forecast period. Established eye care facilities, technological advancements in retinal diagnostics, and increasing attention to early detection of vision-related conditions are supporting market development.
Competitive Landscape and Future Outlook
The electroretinogram market includes specialized ophthalmic diagnostic equipment manufacturers and medical technology companies. Key participants include LKC Technologies, Inc., Diagnosys LLC, Electro-Diagnostic Imaging, Inc., Diopsys, Inc., Metrovision, Roland Consult, and CSO Italia. The cumulative market share of leading players is not publicly disclosed or reliably verifiable.
Established companies compete through diagnostic accuracy, device portability, product innovation, clinical performance, and distribution networks. Specialized and regional manufacturers focus on affordable equipment, customized testing solutions, and partnerships with hospitals and ophthalmology centers. Continued investment in portable ERG devices, digital analysis, and advanced retinal testing is expected to shape market development through 2034.
For more information, visit: https://straitsresearch.com/report/electroretinogram-market
